Many biotechs
Lose money. MIR, same as here had trouble paying bills, as did Sona. Both are doing relatively well. As to Doctors receiving kickbacks in the 2016 report, drug companies present day do it ALL the time. Patients not having to pay for tests in 2016, is similar to before MJ legalization in Canada, Aurora Cannabis specifically : paid their medical patients dispensing fees, and the full taxes on the medical cannabis and wrote those costs down. They were not chastised for that. As to Un necessary tests in 2016, this is a different animal. These tests are necessary for opening up the Country and ongoing maintenance after the fact. As to the charge of $3 for a blood draw trumped up to $17, that reminds of an era whence military vehicle maintenance by an outside consortium was allowed for years to charge at least triplicate of costs of parts and repairs. In fact, it was much higher. This is indeed at this time a penny stock. Sona was 1 penny a share in December 2019.Yesterday, they hit an all time high in the $2.80's. That's a 28,000% increase in 5 months. Sona and Mir both have had difficulties paying bills, and if one digs deep enough, dirt can be found on anyone for political or self gain should they choose. VM